WO2000035919A3 - Composes - Google Patents

Composes Download PDF

Info

Publication number
WO2000035919A3
WO2000035919A3 PCT/EP1999/009564 EP9909564W WO0035919A3 WO 2000035919 A3 WO2000035919 A3 WO 2000035919A3 EP 9909564 W EP9909564 W EP 9909564W WO 0035919 A3 WO0035919 A3 WO 0035919A3
Authority
WO
WIPO (PCT)
Prior art keywords
quinoline derivatives
processes
preparation
treatment
compositions containing
Prior art date
Application number
PCT/EP1999/009564
Other languages
English (en)
Other versions
WO2000035919A2 (fr
Inventor
Laramie Mary Gaster
Tom Daniel Heightman
Original Assignee
Smithkline Beecham Plc
Laramie Mary Gaster
Tom Daniel Heightman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to HU0104662A priority Critical patent/HUP0104662A2/hu
Application filed by Smithkline Beecham Plc, Laramie Mary Gaster, Tom Daniel Heightman filed Critical Smithkline Beecham Plc
Priority to KR1020017007626A priority patent/KR20010108028A/ko
Priority to EP99964526A priority patent/EP1140946A2/fr
Priority to AU30360/00A priority patent/AU3036000A/en
Priority to JP2000588178A priority patent/JP2002532501A/ja
Priority to CA002355234A priority patent/CA2355234A1/fr
Priority to PL99353156A priority patent/PL353156A1/xx
Priority to BR9916307-1A priority patent/BR9916307A/pt
Priority to IL14378299A priority patent/IL143782A0/xx
Publication of WO2000035919A2 publication Critical patent/WO2000035919A2/fr
Publication of WO2000035919A3 publication Critical patent/WO2000035919A3/fr
Priority to NO20013003A priority patent/NO20013003L/no
Priority to HK02101212.8A priority patent/HK1041480A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

La présente invention concerne des dérivés quinoliniques pharmacologiquement actifs, des procédés permettant leur élaboration, des compositions les contenant et leur utilisation pour le traitement de troubles du système nerveux central.
PCT/EP1999/009564 1998-12-17 1999-12-03 Composes WO2000035919A2 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CA002355234A CA2355234A1 (fr) 1998-12-17 1999-12-03 Composes
KR1020017007626A KR20010108028A (ko) 1998-12-17 1999-12-03 퀴놀린 유도체
EP99964526A EP1140946A2 (fr) 1998-12-17 1999-12-03 Composes
AU30360/00A AU3036000A (en) 1998-12-17 1999-12-03 Compounds
JP2000588178A JP2002532501A (ja) 1998-12-17 1999-12-03 キノリン誘導体
HU0104662A HUP0104662A2 (hu) 1998-12-17 1999-12-03 Kombinált 5HT1A, 5HT1B és 5HT1D receptor antagonista aktivitással rendelkező kinolinszármazékok, eljárás az előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
PL99353156A PL353156A1 (en) 1998-12-17 1999-12-03 Compounds
BR9916307-1A BR9916307A (pt) 1998-12-17 1999-12-03 Derivados quinolina
IL14378299A IL143782A0 (en) 1998-12-17 1999-12-03 Quinoline derivatives
NO20013003A NO20013003L (no) 1998-12-17 2001-06-15 Kinolin-derivater
HK02101212.8A HK1041480A1 (zh) 1998-12-17 2002-02-19 喹啉衍生物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9827882.3A GB9827882D0 (en) 1998-12-17 1998-12-17 Novel compounds
GB9827882.3 1998-12-17

Publications (2)

Publication Number Publication Date
WO2000035919A2 WO2000035919A2 (fr) 2000-06-22
WO2000035919A3 true WO2000035919A3 (fr) 2000-10-26

Family

ID=10844468

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/009564 WO2000035919A2 (fr) 1998-12-17 1999-12-03 Composes

Country Status (17)

Country Link
EP (1) EP1140946A2 (fr)
JP (1) JP2002532501A (fr)
KR (1) KR20010108028A (fr)
CN (1) CN1335850A (fr)
AU (1) AU3036000A (fr)
BR (1) BR9916307A (fr)
CA (1) CA2355234A1 (fr)
CO (1) CO5150146A1 (fr)
CZ (1) CZ20012151A3 (fr)
GB (1) GB9827882D0 (fr)
HK (1) HK1041480A1 (fr)
HU (1) HUP0104662A2 (fr)
IL (1) IL143782A0 (fr)
NO (1) NO20013003L (fr)
PL (1) PL353156A1 (fr)
TR (1) TR200101764T2 (fr)
WO (1) WO2000035919A2 (fr)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946278B2 (en) 2007-02-07 2015-02-03 Glaxosmithkline Llc Inhibitors of AkT activity
US9115115B1 (en) 2014-08-19 2015-08-25 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
US9126974B2 (en) 2013-10-17 2015-09-08 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9156813B1 (en) 2014-09-12 2015-10-13 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
US9199964B1 (en) 2014-07-31 2015-12-01 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
US9199942B2 (en) 2013-10-17 2015-12-01 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9255082B2 (en) 2013-10-17 2016-02-09 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9255083B2 (en) 2013-10-17 2016-02-09 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9255081B1 (en) 2014-07-31 2016-02-09 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
US9260396B2 (en) 2013-10-17 2016-02-16 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9371310B2 (en) 2014-07-31 2016-06-21 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
US9414594B2 (en) 2013-10-17 2016-08-16 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9491944B2 (en) 2013-10-22 2016-11-15 Dow Agrosciences Llc Pesticidal compositions and related methods
US9497966B2 (en) 2013-10-22 2016-11-22 Dow Agrosciences Llc Pesticidal compositions and related methods
US9549560B2 (en) 2013-10-22 2017-01-24 Dow Agrosciences Llc Pesticidal compositions and related methods

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9926303D0 (en) * 1999-11-05 2000-01-12 Smithkline Beecham Plc Novel compounds
WO2003000253A1 (fr) * 2001-06-20 2003-01-03 Wyeth Derives d'acide indole substitue utilises en tant qu'inhibiteurs de l'inhibiteur-1 (pai-1) de l'activateur plasminogene
EP1844771A3 (fr) * 2001-06-20 2007-11-07 Wyeth Dérives d'acide indole substitue utilises en tant qu'inhibiteurs de l'inhibiteur-1 (PAI-1) de l'activateur plasminogene
TWI224101B (en) 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
AU2002352878B2 (en) 2001-11-27 2007-11-22 Merck Sharp & Dohme Corp. 2-Aminoquinoline compounds
UA80453C2 (en) 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
MXPA05006287A (es) 2002-12-10 2005-09-08 Wyeth Corp Derivados de acido indoloxo-acetilaminoacetico sustituidos como inhibidores del inhibidor del activador de plasminogeno 1 (pai-1).
CA2509191A1 (fr) 2002-12-10 2004-06-24 Wyeth Derives d'acide 1h-indol-3-yl glyoxylique a substitution aryle, aryloxy et alkyloxy en tant qu'inhibiteurs de l'inhibiteur de l'activateur du plasminogene-1 (pai-1)
WO2004052853A2 (fr) 2002-12-10 2004-06-24 Wyeth Derives substitues de l'acide acetique de 3-alkyle et 3-arylalkyle 1h-indol-1-yle en tant qu'inhibiteurs de l'inhibiteur des activateurs du plasminogene (pai-1)
CN1726190A (zh) 2002-12-10 2006-01-25 惠氏公司 作为纤溶酶原激活物抑制剂－1(pai－1)的抑制剂的取代3－羰基－1h－吲哚－1－基乙酸衍生物
US7446201B2 (en) 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7351726B2 (en) 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7442805B2 (en) 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7332521B2 (en) 2003-09-25 2008-02-19 Wyeth Substituted indoles
US7141592B2 (en) 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7582773B2 (en) 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
US7265148B2 (en) 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
US7163954B2 (en) 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
US7268159B2 (en) 2003-09-25 2007-09-11 Wyeth Substituted indoles
CN1890234A (zh) 2003-12-23 2007-01-03 辉瑞大药厂 新颖的喹啉衍生物
ES2775125T3 (es) 2010-11-03 2020-07-23 Dow Agrosciences Llc Composiciones plaguicidas y procedimientos relacionados
US8937083B2 (en) 2011-10-26 2015-01-20 DowAgroSciences, LLC Pesticidal compositions and processes related thereto
MA37572B1 (fr) 2012-04-27 2017-10-31 Dow Agrosciences Llc Compositions pesticides et procédés correspondants
US9708288B2 (en) 2012-04-27 2017-07-18 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US10092574B2 (en) 2012-09-26 2018-10-09 Valorisation-Recherche, Limited Partnership Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof
WO2015058020A1 (fr) 2013-10-17 2015-04-23 Dow Agrosciences Llc Procédés de préparation de composés pesticides
NZ719634A (en) 2013-10-22 2017-09-29 Dow Agrosciences Llc Pesticidal compositions and related methods
EP3060043A4 (fr) 2013-10-22 2017-04-12 Dow AgroSciences, LLC Compositions pesticides et procédés associés
US9295258B2 (en) 2013-10-22 2016-03-29 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
WO2015061142A1 (fr) 2013-10-22 2015-04-30 Dow Agrosciences Llc Compositions pesticides synergiques et procédés associés
KR20160077113A (ko) 2013-10-22 2016-07-01 다우 아그로사이언시즈 엘엘씨 살충 조성물 및 관련 방법
TW201519775A (zh) 2013-10-22 2015-06-01 Dow Agrosciences Llc 協同性殺蟲組成物及相關方法（七）
JP2016538266A (ja) 2013-10-22 2016-12-08 ダウ アグロサイエンシィズ エルエルシー 相乗的有害生物防除組成物および関連する方法
EP3094183A4 (fr) 2013-10-22 2017-08-09 Dow AgroSciences LLC Compositions pesticides synergiques et procédés associés
EP3060042A4 (fr) 2013-10-22 2017-04-26 Dow AgroSciences LLC Compositions pesticides synergiques et procédés associés
JP2016534068A (ja) 2013-10-22 2016-11-04 ダウ アグロサイエンシィズ エルエルシー 相乗的有害生物防除組成物および関連する方法
TW201519778A (zh) 2013-10-22 2015-06-01 Dow Agrosciences Llc 協同性殺蟲組成物及相關方法（十）
RU2016119553A (ru) 2013-10-22 2017-12-04 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Синергетические пестицидные композиции и связанные с ними способы
RU2016119530A (ru) 2013-10-22 2017-11-28 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Синергетические пестицидные композиции и относящиеся к ним способы
NZ719754A (en) 2013-10-22 2017-06-30 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
WO2018125815A1 (fr) 2016-12-29 2018-07-05 Dow Agrosciences Llc Procédés de préparation de composés pesticides
WO2018125817A1 (fr) 2016-12-29 2018-07-05 Dow Agrosciences Llc Procédés de préparation de composés pesticides
CN108570450A (zh) * 2017-03-11 2018-09-25 华中科技大学鄂州工业技术研究院 一种细胞模型及其构建和筛选五羟色胺受体靶点活性物质之应用
CN106883192B (zh) * 2017-03-30 2019-05-14 苏州汉德创宏生化科技有限公司 含氮类杂环抗肿瘤药物活性物恶唑基修饰的苯甲酸类化合物的合成方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006644A1 (fr) * 1993-09-03 1995-03-09 Smithkline Beecham Plc Derives d'amide en tant qu'antagonistes du recepteur de 5ht1d
WO1998047868A1 (fr) * 1997-04-18 1998-10-29 Smithkline Beecham Plc Derives d'uree contenant un heterocycle utilises comme antagonistes des recepteurs 5ht1a, 5ht1b et 5ht¿1d?
WO1998050358A1 (fr) * 1997-04-18 1998-11-12 Smithkline Beecham Plc Derives indoliques a activite de recepteur antagoniste 5ht1a, 5ht1b, 5ht1d
WO1999031086A1 (fr) * 1997-12-12 1999-06-24 Smithkline Beecham Plc Derives de quinoleinepiperazine et de quinoleinepiperidine, leur preparation et leur utilisation en tant qu'antagonistes combines des recepteurs 5-ht1a, 5-ht1b et 5-ht1d

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006644A1 (fr) * 1993-09-03 1995-03-09 Smithkline Beecham Plc Derives d'amide en tant qu'antagonistes du recepteur de 5ht1d
WO1998047868A1 (fr) * 1997-04-18 1998-10-29 Smithkline Beecham Plc Derives d'uree contenant un heterocycle utilises comme antagonistes des recepteurs 5ht1a, 5ht1b et 5ht¿1d?
WO1998050358A1 (fr) * 1997-04-18 1998-11-12 Smithkline Beecham Plc Derives indoliques a activite de recepteur antagoniste 5ht1a, 5ht1b, 5ht1d
WO1999031086A1 (fr) * 1997-12-12 1999-06-24 Smithkline Beecham Plc Derives de quinoleinepiperazine et de quinoleinepiperidine, leur preparation et leur utilisation en tant qu'antagonistes combines des recepteurs 5-ht1a, 5-ht1b et 5-ht1d

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946278B2 (en) 2007-02-07 2015-02-03 Glaxosmithkline Llc Inhibitors of AkT activity
US9447048B2 (en) 2013-10-17 2016-09-20 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9580405B2 (en) 2013-10-17 2017-02-28 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9260396B2 (en) 2013-10-17 2016-02-16 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9540342B2 (en) 2013-10-17 2017-01-10 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9199942B2 (en) 2013-10-17 2015-12-01 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9255082B2 (en) 2013-10-17 2016-02-09 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9255083B2 (en) 2013-10-17 2016-02-09 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9414594B2 (en) 2013-10-17 2016-08-16 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9550751B2 (en) 2013-10-17 2017-01-24 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9126974B2 (en) 2013-10-17 2015-09-08 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9434712B2 (en) 2013-10-17 2016-09-06 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9433215B2 (en) 2013-10-17 2016-09-06 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
US9549560B2 (en) 2013-10-22 2017-01-24 Dow Agrosciences Llc Pesticidal compositions and related methods
US9491944B2 (en) 2013-10-22 2016-11-15 Dow Agrosciences Llc Pesticidal compositions and related methods
US9497966B2 (en) 2013-10-22 2016-11-22 Dow Agrosciences Llc Pesticidal compositions and related methods
US9573931B2 (en) 2014-07-31 2017-02-21 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
US9255081B1 (en) 2014-07-31 2016-02-09 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
US9371310B2 (en) 2014-07-31 2016-06-21 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
US9199964B1 (en) 2014-07-31 2015-12-01 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
US9580403B2 (en) 2014-07-31 2017-02-28 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
US9522900B2 (en) 2014-08-19 2016-12-20 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
US9115115B1 (en) 2014-08-19 2015-08-25 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
US9422265B2 (en) 2014-09-12 2016-08-23 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
US9156813B1 (en) 2014-09-12 2015-10-13 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine

Also Published As

Publication number Publication date
HK1041480A1 (zh) 2002-07-12
KR20010108028A (ko) 2001-12-07
AU3036000A (en) 2000-07-03
BR9916307A (pt) 2002-01-15
IL143782A0 (en) 2002-04-21
NO20013003L (no) 2001-07-25
WO2000035919A2 (fr) 2000-06-22
EP1140946A2 (fr) 2001-10-10
CZ20012151A3 (cs) 2001-12-12
HUP0104662A2 (hu) 2002-04-29
CA2355234A1 (fr) 2000-06-22
CO5150146A1 (es) 2002-04-29
JP2002532501A (ja) 2002-10-02
NO20013003D0 (no) 2001-06-15
CN1335850A (zh) 2002-02-13
GB9827882D0 (en) 1999-02-10
TR200101764T2 (tr) 2001-10-22
PL353156A1 (en) 2003-10-20

Similar Documents

Publication Publication Date Title
WO2000035919A3 (fr) Composes
WO2002041889A3 (fr) Composes utiles pour le traitement de troubles du snc
MY138836A (en) Quinoline derivatives and their use as 5-ht6 receptor ligands
GB0111186D0 (en) Novel compounds
CA2250372A1 (fr) Derives de 6-phenylpyridyl-2-amines
EP1143956A3 (fr) Compositions et techniques de traitement de troubles anorectaux
IL142768A0 (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
WO2002072536A8 (fr) Derives d'uree ayant une activite antagoniste du recepteur vanilloide (vr1)
WO1999002502A3 (fr) Nouveaux composes
TW200500344A (en) Novel compounds
HUP9701096A3 (en) Use of benzenesulfonamides for the preparation of pharmaceutical compositions treating disorders of the central nervous system, novel derivatives, process for their preparation and pharmaceutical compositions containing them
CA2273479A1 (fr) Derives de 6-phenylpyridyl-2-amine utiles comme inhibiteur nos
CA2343236A1 (fr) Derives de 4,4-biarylpiperidine
HUP0301167A3 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders, process for their preparation, pharmaceutical compositions containing them and their use
AU3126600A (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
HUP9701193A3 (en) Use of n-(4-aryl-thiazol-2-yl)-sulfonamide derivatives for the preparation of pharmaceutical compositions treating neurological disorders, new derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0200284A3 (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders, process for their preparation and pharmaceutical compositions containing them
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
WO1996023769A3 (fr) Composes heterocycliques possedant une activite antagoniste vis-a-vis du recepteur de 5ht¿2c?
GB0320320D0 (en) Novel compounds
UY26426A1 (es) Nuevos compuestos
HUP0103832A3 (en) Triazolopyridines for the treatment of thrombosis disorders, pharmaceutical compositions containing the same and process for preparation thereof
WO2001098269A3 (fr) N-ureidoalkyl-piperidines utiles comme modulateurs de l'activite du recepteur de chimiokine
WO1998027058A3 (fr) Nouveaux composes
WO2002051848A3 (fr) Sulfamidothienopyrimidines

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99816080.6

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 30360/00

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2355234

Country of ref document: CA

Ref document number: 2355234

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PV2001-2151

Country of ref document: CZ

Ref document number: 143782

Country of ref document: IL

ENP Entry into the national phase

Ref document number: 2000 588178

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 512401

Country of ref document: NZ

Ref document number: 200104925

Country of ref document: ZA

Ref document number: IN/PCT/2001/00517/DE

Country of ref document: IN

Ref document number: 2001/01764

Country of ref document: TR

WWE Wipo information: entry into national phase

Ref document number: 1020017007626

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/006243

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1999964526

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09868291

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999964526

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1020017007626

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: PV2001-2151

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1999964526

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV2001-2151

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1020017007626

Country of ref document: KR